Home › Brand search › MULTIMAB

Is MULTIMAB trademarked in India?

1 application advertised in the Trade Marks Journal · class 1 · latest 15 January 2024

Yes, "MULTIMAB" has been applied for as a trademark in India. 1 application under this name was advertised in the Trade Marks Journal on 15 January 2024, in class 1 (chemicals), by Cell Signaling Technology, INC.. The opposition window has closed.

1 application named MULTIMAB

ApplicationClassApplicantFiledAdvertisedOpposition
6015697MULTIMAB 1Chemicals Cell Signaling Technology, INC. 11 July 2023 No. 213915 January 2024 closed15 May 2024

Goods and services claimed

Class 1: Chemicals · application 6015697

Antibodies, enzymes and nucleic acids for scientific and research use; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry, and microbiology; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; biochemicals, namely, monoclonal antibodies for in vitro scientific or research…

Proposed to be used · Chennai office · full journal entry

Can I use or register "MULTIMAB"?

For the same or related goods, probably not. In class 1 (chemicals), a new application for an identical or confusingly similar name is likely to be objected to by the Registry under Section 11 of the Trade Marks Act, 1999, or opposed by the earlier applicant. Closely related classes, such as class 5 (pharmaceuticals and health), class 35 (advertising, business and retail) and class 31 (fresh produce and agriculture), carry the same risk.

For unrelated goods, often yes. The same word can be registered by different owners in different classes when the goods are unrelated and the earlier mark is not well known. "MULTIMAB" appears in 1 class; the other 44 may still be open, subject to a search.

A small change rarely helps. Adding a word, changing a letter or using a logo does not avoid conflict on its own: marks are compared as a whole, by look, sound and idea.

Want a name like MULTIMAB? Check yours free

Tell us your brand name and what you sell. A Trademark Attorney searches the journal register for identical and similar marks in your class and emails you a short report.

If your name is clear, we file it for you: ₹14,999 professional fee per class, one package from filing to publication in the Trade Marks Journal, plus the government fee of ₹4,500 per class for individuals and small businesses (₹9,000 for other companies). No hidden fees.

A registered Trademark Attorney reviews every report. We reply by email, usually within 24 hours.

Is MULTIMAB your brand? Watch it freeWe read every weekly journal issue, logos included, and email you when a similar name is advertised, while you can still oppose it. Ask a Trademark AttorneyDoes this name affect your brand? Ask on WhatsApp. The first answer is free. Which class is mine?Describe your business and get the classes to file in, with the traps for your trade.

Similar names in the journal

Matched by spelling and containment across every issue since August 2021. Our free report and Brand Watch also check sounds-alike names.

Questions about MULTIMAB

Is MULTIMAB a registered trademark?

MULTIMAB has been applied for and advertised in the Trade Marks Journal (1 application, latest on 15 January 2024). Advertisement means the Registry accepted the application; it is registered only if no opposition succeeds within four months of the journal date. The journal does not record the later outcome, so check the live register before relying on it.

Who applied for the MULTIMAB trademark?

As advertised: Cell Signaling Technology, INC..

Can I register a trademark similar to MULTIMAB?

Not for the same or related goods in class 1: a confusingly similar name is likely to be refused or opposed. For unrelated goods it may be possible after a search. Ask for a free availability report before you file.

What does "advertised" mean? Read trademark status meanings, how long registration takes and how to run a trademark search.

Source and limits. Built from the Trade Marks Journal published by the Registrar of Trade Marks (a public record), issues from August 2021 onwards, as advertised and subject to transcription errors. The journal shows that an application was accepted and advertised; it does not show what happened afterwards (registration, opposition, withdrawal or abandonment), applications not yet advertised, or marks advertised before August 2021, so this is not the live register status. Applicants may ask for a correction or removal by writing to mehak@trademarkindia.pro. Information only, not legal advice and not a solicitation.

WhatsApp us